Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
grade A 18.91 -5.97% -1.20
CBMG closed down 5.97 percent on Friday, January 18, 2019, on 1.38 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CBMG trend table...

Date Alert Name Type % Chg
Jan 18 200 DMA Support Bullish 0.00%
Jan 18 Multiple of Ten Bearish Other 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Crossed Above 200 DMA Bullish -5.97%
Jan 17 MACD Bullish Signal Line Cross Bullish -5.97%
Jan 17 Expansion Pivot Buy Setup Bullish Swing Setup -5.97%
Jan 17 Pocket Pivot Bullish Swing Setup -5.97%
Jan 17 Multiple of Ten Bullish Other -5.97%
Jan 17 Up 3 Days in a Row Strength -5.97%
Jan 17 Upper Bollinger Band Touch Strength -5.97%

Older signals for CBMG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.
Is CBMG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.0
52 Week Low 12.04
Average Volume 89,319
200-Day Moving Average 18.753
50-Day Moving Average 18.2502
20-Day Moving Average 18.158
10-Day Moving Average 18.698
Average True Range 1.3309
ADX 16.91
+DI 22.3996
-DI 16.0399
Chandelier Exit (Long, 3 ATRs ) 16.5073
Chandelier Exit (Short, 3 ATRs ) 19.2027
Upper Bollinger Band 20.3745
Lower Bollinger Band 15.9415
Percent B (%b) 0.67
BandWidth 24.413482
MACD Line 0.2087
MACD Signal Line 0.1386
MACD Histogram 0.0701
Fundamentals Value
Market Cap 266.79 Million
Num Shares 14.1 Million
EPS -2.06
Price-to-Earnings (P/E) Ratio -9.18
Price-to-Sales 587.89
Price-to-Book 2.44
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.54
Resistance 3 (R3) 21.77 21.14 21.10
Resistance 2 (R2) 21.14 20.47 21.02 20.95
Resistance 1 (R1) 20.02 20.06 19.71 19.79 20.81
Pivot Point 19.39 19.39 19.23 19.27 19.39
Support 1 (S1) 18.27 18.72 17.96 18.04 17.01
Support 2 (S2) 17.64 18.31 17.52 16.87
Support 3 (S3) 16.52 17.64 16.72
Support 4 (S4) 16.29